Beginning in September 2019, manufacturers of Zantac and other brands of the heartburn drug ranitidine began issuing recalls for their product. The Food and Drug administration (FDA) issued a market-wide recall in April 2020, due to their findings that ranitidine contains a potent carcinogen: N-Nitrosodimethylamine, or NDMA. Even worse: the level of NDMA in ranitidine increases over time when it’s stored in normal conditions, and when being digested by the patient’s body.
If you took Zantac before the recall and have developed cancer as a result, you could be entitled to compensation through a defective drug mass tort lawsuit. Call the experienced mass tort lawyers at Gordon McKernan Injury Attorneys at 888.501.7888 today for a free consultation as to your legal options.
GET HELP NOW!